[{"address1": "7750 El Camino Real", "address2": "Suite 2A", "city": "Carlsbad", "state": "CA", "zip": "92009", "country": "United States", "phone": "858 704 4900", "website": "https://www.palisadebio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The company's lead therapeutic candidate is PALI-2108, a prodrug PDE4 inhibitor that is in phase 1a/b clinical trial for the treatment of ulcerative colitis, as well as under phase 1a clinical trial for the treatment of fibrostenotic crohn's disease. It has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; a license agreement with the Regents of the University of California for sole purpose of maintaining the Newsoara Co-Development; and a co-development and distribution agreement with Newsoara Biopharma Co., Ltd. The company is headquartered in Carlsbad, California.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Mr. J. D. Finley", "age": 67, "title": "CEO, CFO & Director", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 813000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mitchell Lawrence Jones M.D., Ph.D.", "age": 47, "title": "COO & Chief Medical Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 581000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Joerg  Heyer Ph.D.", "title": "Head of Translational Science & Medicine", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.94, "open": 1.99, "dayLow": 1.92, "dayHigh": 2.09, "regularMarketPreviousClose": 1.94, "regularMarketOpen": 1.99, "regularMarketDayLow": 1.92, "regularMarketDayHigh": 2.09, "payoutRatio": 0.0, "beta": 1.473, "forwardPE": -0.22697368, "volume": 4933576, "regularMarketVolume": 4933576, "averageVolume": 8350110, "averageVolume10days": 4920840, "averageDailyVolume10Day": 4920840, "bid": 2.0, "ask": 2.1, "bidSize": 9, "askSize": 7, "marketCap": 289312672, "fiftyTwoWeekLow": 0.53, "fiftyTwoWeekHigh": 3.3, "allTimeHigh": 5627700.0, "allTimeLow": 0.53, "fiftyDayAverage": 1.1906, "twoHundredDayAverage": 0.9473, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 13787645, "profitMargins": 0.0, "floatShares": 6077368, "sharesOutstanding": 139564572, "sharesShort": 5920702, "sharesShortPriorMonth": 497201, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.0444, "heldPercentInsiders": 0.00017000001, "heldPercentInstitutions": 0.33763, "shortRatio": 0.38, "shortPercentOfFloat": 0.044499997, "impliedSharesOutstanding": 139764572, "bookValue": 0.545, "priceToBook": 3.7981648, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -11845000, "trailingEps": -3.64, "forwardEps": -9.12, "lastSplitFactor": "1:15", "lastSplitDate": 1712534400, "enterpriseToEbitda": -1.137, "52WeekChange": -0.2553957, "SandP52WeekChange": 0.19736934, "quoteType": "EQUITY", "currentPrice": 2.07, "targetHighPrice": 21.0, "targetLowPrice": 2.0, "targetMeanPrice": 10.33333, "targetMedianPrice": 8.0, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 5429000, "totalCashPerShare": 0.595, "ebitda": -12125000, "totalDebt": 338000, "quickRatio": 1.369, "currentRatio": 1.624, "debtToEquity": 12.901, "returnOnAssets": -0.77592003, "returnOnEquity": -1.8848, "freeCashflow": -6058500, "operatingCashflow": -9664000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PALI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "exchange": "NCM", "messageBoardId": "finmb_244367385", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 6.70102, "regularMarketPrice": 2.07, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1175261400000, "postMarketChangePercent": -0.9613452, "postMarketPrice": 2.0501, "postMarketChange": -0.019899845, "regularMarketChange": 0.13, "regularMarketDayRange": "1.92 - 2.09", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 8350110, "fiftyTwoWeekLowChange": 1.54, "fiftyTwoWeekLowChangePercent": 2.9056604, "fiftyTwoWeekRange": "0.53 - 3.3", "fiftyTwoWeekHighChange": -1.23, "fiftyTwoWeekHighChangePercent": -0.37272727, "fiftyTwoWeekChangePercent": -25.539572, "dividendDate": 1563408000, "earningsTimestampStart": 1754942400, "earningsTimestampEnd": 1755288000, "isEarningsDateEstimate": true, "shortName": "Palisade Bio, Inc.", "longName": "Palisade Bio, Inc.", "epsTrailingTwelveMonths": -3.64, "epsForward": -9.12, "epsCurrentYear": -1.72333, "priceEpsCurrentYear": -1.2011628, "fiftyDayAverageChange": 0.8793999, "fiftyDayAverageChangePercent": 0.7386191, "twoHundredDayAverageChange": 1.1227, "twoHundredDayAverageChangePercent": 1.1851578, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Seneca Biopharma, Inc.", "nameChangeDate": "2025-10-31", "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1761954937, "regularMarketTime": 1761940801, "displayName": "Palisade Bio", "trailingPegRatio": null, "__fetch_time": "2025-11-01"}]